Case Reports
doi: 10.1016/j.jinf.2005.05.005.
Epub 2005 Jun 13.
Vogt-Koyanagi-Harada disease associated with interferon-A and ribavirin therapy for chronic hepatitis C infection
Affiliations
- PMID: 15951019
- DOI: 10.1016/j.jinf.2005.05.005
Item in Clipboard
Case Reports
Vogt-Koyanagi-Harada disease associated with interferon-A and ribavirin therapy for chronic hepatitis C infection
J Infect.
2006 Feb.
Abstract
A rare case of Vogt-Koyanagi-Harada disease associated with ribavirin and interferon-alpha treatment for chronic hepatitis C infection is presented. The potential role of interferon and/or ribavirin therapy is discussed. Physicians should be aware of the association between interferon-alpha and ribavirin use for hepatitis C infection and the development of Harada's disease. Close monitoring of such patients for ocular side effects is necessary.
Similar articles
-
Vogt-Koyanagi-Harada disease occurring during interferon-alpha and ribavirin therapy for chronic hepatitis C virus infection.Int Ophthalmol. 2010 Oct;30(5):611-3. doi: 10.1007/s10792-010-9357-0. Epub 2010 Feb 23. Int Ophthalmol. 2010. PMID: 20177954
-
[Vogt-Koyanagi-Harada disease associated with interferon-alpha and ribavirin therapy for chronic hepatitis C infection].J Fr Ophtalmol. 2010 Mar;33(3):185-8. doi: 10.1016/j.jfo.2010.01.009. Epub 2010 Feb 20. J Fr Ophtalmol. 2010. PMID: 20172621 French.
-
Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C.Korean J Hepatol. 2011 Mar;17(1):61-5. doi: 10.3350/kjhep.2011.17.1.61. Korean J Hepatol. 2011. PMID: 21494079 Free PMC article.
-
Induction of Vogt-Koyanagi-Harada Disease by Interferon-Alpha and Ribavirin Treatment in Patients with Hepatitis C: A Case Report and Review of the Literature.Ocul Immunol Inflamm. 2019;27(2):229-234. doi: 10.1080/09273948.2017.1373827. Epub 2017 Oct 12. Ocul Immunol Inflamm. 2019. PMID: 29023176 Review.
-
Vogt-Koyanagi-Harada disease occurring during interferon alpha therapy for chronic hepatitis C.J Gastroenterol. 2004 Nov;39(11):1106-9. doi: 10.1007/s00535-004-1452-4. J Gastroenterol. 2004. PMID: 15580406 Review.
Cited by
-
Intraocular complications of IFN-alpha and ribavirin therapy in patients with chronic viral hepatitis C.World J Gastroenterol. 2007 Jun 14;13(22):3137-40. doi: 10.3748/wjg.v13.i22.3137. World J Gastroenterol. 2007. PMID: 17589934 Free PMC article.
-
Sofosbuvir/Ribavirin therapy for patients experiencing failure of ombitasvir/paritaprevir/ritonavir + ribavirin therapy: Two cases report and review of literature.World J Clin Cases. 2019 May 6;7(9):1043-1052. doi: 10.12998/wjcc.v7.i9.1043. World J Clin Cases. 2019. PMID: 31123677 Free PMC article.
-
RELATIONSHIP BETWEEN UVEITIS, DIFFERENT TYPES OF VIRAL HEPATITIS, AND LIVER CIRRHOSIS: A 12-Year Nationwide Population-Based Cohort Study.Retina. 2016 Dec;36(12):2391-2398. doi: 10.1097/IAE.0000000000001103. Retina. 2016. PMID: 27870801 Free PMC article.
-
Serous Retinal Detachments Complicating Interferon-α and Ribavirin Treatment in Patients with Hepatitis C.Case Rep Ophthalmol. 2011 Jan;2(1):105-10. doi: 10.1159/000326747. Epub 2011 Mar 12. Case Rep Ophthalmol. 2011. PMID: 22110438 Free PMC article.
-
Vogt-Koyanagi-Harada disease occurring during interferon-alpha and ribavirin therapy for chronic hepatitis C virus infection.Int Ophthalmol. 2010 Oct;30(5):611-3. doi: 10.1007/s10792-010-9357-0. Epub 2010 Feb 23. Int Ophthalmol. 2010. PMID: 20177954
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
